title: Response to Degenhardt et al.: 'depot naltrexone use for opioid dependence in Australia: large-scale use of an unregistered medication in the absence of data on safety and efficacy'.
authors.forename: Colin
authors.initials: C
authors.lastname: Brewer
mesh_terms: D001315:Australia; D004343:Drug Implants; D006801:Humans; D007880:Legislation, Drug; D009271:Naltrexone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D009292:Narcotic Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D009293:Opioid-Related Disorders / Q000517:prevention & control*
chemical_list: D004343:Drug Implants; D009292:Narcotic Antagonists; D009271:Naltrexone